You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Metabolic Disorders Drugs Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot
The global Metabolic Disorders Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Metabolic Disorders Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Tablet
Injection
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Zealand Pharma
Rhythm
OxThera
Biophytis
Biophytis
Zafgen
PerkinElmer
Eternygen
Pronutria Biosciences
MedGenome
CellCentric
Nimbus Therapeutics
Mitobridge
Exelixis, Inc.
Outpost Medicine
Anchor Therapeutics
Verva Pharmaceuticals
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Diabetes
Disorders of the Thyroid and Pituitary Gland
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Metabolic Disorders Drugs Industry
Figure Metabolic Disorders Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Metabolic Disorders Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Metabolic Disorders Drugs
1.2.2 Downstream
Table Application Segment of Metabolic Disorders Drugs
Table Global Metabolic Disorders Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Metabolic Disorders Drugs Market by Type
3.1 By Type
3.1.1 Tablet
Table Major Company List of Tablet
3.1.2 Injection
Table Major Company List of Injection
3.2 Market Size
Table Global Metabolic Disorders Drugs Market 2016-2020, by Type, in USD Million
Figure Global Metabolic Disorders Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Metabolic Disorders Drugs Market 2016-2020, by Type, in Volume
Figure Global Metabolic Disorders Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Metabolic Disorders Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Metabolic Disorders Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Zealand Pharma (Company Profile, Sales Data etc.)
4.1.1 Zealand Pharma Profile
Table Zealand Pharma Overview List
4.1.2 Zealand Pharma Products & Services
4.1.3 Zealand Pharma Business Operation Conditions
Table Business Operation of Zealand Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Rhythm (Company Profile, Sales Data etc.)
4.2.1 Rhythm Profile
Table Rhythm Overview List
4.2.2 Rhythm Products & Services
4.2.3 Rhythm Business Operation Conditions
Table Business Operation of Rhythm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 OxThera (Company Profile, Sales Data etc.)
4.3.1 OxThera Profile
Table OxThera Overview List
4.3.2 OxThera Products & Services
4.3.3 OxThera Business Operation Conditions
Table Business Operation of OxThera (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Biophytis (Company Profile, Sales Data etc.)
4.4.1 Biophytis Profile
Table Biophytis Overview List
4.4.2 Biophytis Products & Services
4.4.3 Biophytis Business Operation Conditions
Table Business Operation of Biophytis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Biophytis (Company Profile, Sales Data etc.)
4.5.1 Biophytis Profile
Table Biophytis Overview List
4.5.2 Biophytis Products & Services
4.5.3 Biophytis Business Operation Conditions
Table Business Operation of Biophytis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Zafgen (Company Profile, Sales Data etc.)
4.6.1 Zafgen Profile
Table Zafgen Overview List
4.6.2 Zafgen Products & Services
4.6.3 Zafgen Business Operation Conditions
Table Business Operation of Zafgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 PerkinElmer (Company Profile, Sales Data etc.)
4.7.1 PerkinElmer Profile
Table PerkinElmer Overview List
4.7.2 PerkinElmer Products & Services
4.7.3 PerkinElmer Business Operation Conditions
Table Business Operation of PerkinElmer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Eternygen (Company Profile, Sales Data etc.)
4.8.1 Eternygen Profile
Table Eternygen Overview List
4.8.2 Eternygen Products & Services
4.8.3 Eternygen Business Operation Conditions
Table Business Operation of Eternygen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Pronutria Biosciences (Company Profile, Sales Data etc.)
4.9.1 Pronutria Biosciences Profile
Table Pronutria Biosciences Overview List
4.9.2 Pronutria Biosciences Products & Services
4.9.3 Pronutria Biosciences Business Operation Conditions
Table Business Operation of Pronutria Biosciences (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 MedGenome (Company Profile, Sales Data etc.)
4.10.1 MedGenome Profile
Table MedGenome Overview List
4.10.2 MedGenome Products & Services
4.10.3 MedGenome Business Operation Conditions
Table Business Operation of MedGenome (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 CellCentric (Company Profile, Sales Data etc.)
4.11.1 CellCentric Profile
Table CellCentric Overview List
4.11.2 CellCentric Products & Services
4.11.3 CellCentric Business Operation Conditions
Table Business Operation of CellCentric (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Nimbus Therapeutics (Company Profile, Sales Data etc.)
4.12.1 Nimbus Therapeutics Profile
Table Nimbus Therapeutics Overview List
4.12.2 Nimbus Therapeutics Products & Services
4.12.3 Nimbus Therapeutics Business Operation Conditions
Table Business Operation of Nimbus Therapeutics (Sales Revenue, Cost, Gross Margin)
4.13 Mitobridge (Company Profile, Sales Data etc.)
4.13.1 Mitobridge Profile
Table Mitobridge Overview List
4.13.2 Mitobridge Products & Services
4.13.3 Mitobridge Business Operation Conditions
Table Business Operation of Mitobridge (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Exelixis, Inc. (Company Profile, Sales Data etc.)
4.14.1 Exelixis, Inc. Profile
Table Exelixis, Inc. Overview List
4.14.2 Exelixis, Inc. Products & Services
4.14.3 Exelixis, Inc. Business Operation Conditions
Table Business Operation of Exelixis, Inc. (Sales Revenue, Cost, Gross Margin)
4.15 Outpost Medicine (Company Profile, Sales Data etc.)
4.15.1 Outpost Medicine Profile
Table Outpost Medicine Overview List
4.15.2 Outpost Medicine Products & Services
4.15.3 Outpost Medicine Business Operation Conditions
Table Business Operation of Outpost Medicine (Sales Revenue, Cost, Gross Margin)
4.16 Anchor Therapeutics (Company Profile, Sales Data etc.)
4.16.1 Anchor Therapeutics Profile
Table Anchor Therapeutics Overview List
4.16.2 Anchor Therapeutics Products & Services
4.16.3 Anchor Therapeutics Business Operation Conditions
Table Business Operation of Anchor Therapeutics (Sales Revenue, Cost, Gross Margin)
4.17 Verva Pharmaceuticals (Company Profile, Sales Data etc.)
4.17.1 Verva Pharmaceuticals Profile
Table Verva Pharmaceuticals Overview List
4.17.2 Verva Pharmaceuticals Products & Services
4.17.3 Verva Pharmaceuticals Business Operation Conditions
Table Business Operation of Verva Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Metabolic Disorders Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Metabolic Disorders Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Metabolic Disorders Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Metabolic Disorders Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Metabolic Disorders Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Metabolic Disorders Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Metabolic Disorders Drugs Market Concentration, in 2020
Figure Europe Metabolic Disorders Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Metabolic Disorders Drugs MMarket Concentration, in 2020
Figure South America Metabolic Disorders Drugs Market Concentration, in 2020
Figure Middle East & Africa Metabolic Disorders Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Diabetes
Figure Metabolic Disorders Drugs Demand in Diabetes, 2016-2020, in USD Million
Figure Metabolic Disorders Drugs Demand in Diabetes, 2016-2020, in Volume
6.1.2 Demand in Disorders of the Thyroid and Pituitary Gland
Figure Metabolic Disorders Drugs Demand in Disorders of the Thyroid and Pituitary Gland, 2016-2020, in USD Million
Figure Metabolic Disorders Drugs Demand in Disorders of the Thyroid and Pituitary Gland, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Metabolic Disorders Drugs Demand in Others, 2016-2020, in USD Million
Figure Metabolic Disorders Drugs Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Metabolic Disorders Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Metabolic Disorders Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Metabolic Disorders Drugs Market Share in 2026, by Application, in USD Million
Table Metabolic Disorders Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Metabolic Disorders Drugs Market Growth 2021-2026, by Application, in Volume
Table Metabolic Disorders Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Metabolic Disorders Drugs Production 2016-2020, by Region, in USD Million
Table Metabolic Disorders Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Metabolic Disorders Drugs Market 2016-2020, by Region, in USD Million
Table Global Metabolic Disorders Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Metabolic Disorders Drugs Market 2016-2020, by Region, in Volume
Table Global Metabolic Disorders Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Metabolic Disorders Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Metabolic Disorders Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Metabolic Disorders Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Metabolic Disorders Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Metabolic Disorders Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Metabolic Disorders Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Metabolic Disorders Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Metabolic Disorders Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Metabolic Disorders Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Metabolic Disorders Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Metabolic Disorders Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Metabolic Disorders Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Metabolic Disorders Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Metabolic Disorders Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Metabolic Disorders Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Metabolic Disorders Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Metabolic Disorders Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Metabolic Disorders Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Metabolic Disorders Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Metabolic Disorders Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Metabolic Disorders Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Metabolic Disorders Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 105